Company intelligence / Profile preview
Uriach
- Ownership
- Private
- Employees
- ~1300
- Development stage
- Commercial
Overview
Uriach has a diversified portfolio of commercialized natural consumer healthcare products and pharmaceuticals. Its science-driven approach has been recognized with over 20 innovation awards in the last five years. The company leads the European market for natural consumer healthcare with direct presence in 11 countries and more than 20 brands. It also offers contract manufacturing services for solid oral dosages and semisolids under GMP/GLP standards.
- Therapeutic areas
- PulmonologyCardiovascularOther
- Modalities
- Small moleculesnatural products/phytopharmaceuticalsgenericsnutraceuticals
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Uriach.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Uriach.